Analysts Set Owens & Minor, Inc. (NYSE:OMI) Price Target at $15.08

Shares of Owens & Minor, Inc. (NYSE:OMI) have received a consensus recommendation of “Hold” from the six brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $13.75.

Several equities analysts have recently issued reports on OMI shares. UBS Group lowered their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, February 13th. JPMorgan Chase & Co. lowered their price objective on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating for the company in a research note on Monday. Finally, Robert W. Baird increased their target price on Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd.

Insider Buying and Selling at Owens & Minor

In other news, major shareholder Coliseum Capital Management, L purchased 1,738,511 shares of the business’s stock in a transaction on Friday, February 28th. The stock was acquired at an average cost of $9.39 per share, for a total transaction of $16,324,618.29. Following the purchase, the insider now directly owns 9,469,698 shares in the company, valued at $88,920,464.22. This trade represents a 22.49 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.59% of the company’s stock.

Hedge Funds Weigh In On Owens & Minor

A number of institutional investors and hedge funds have recently made changes to their positions in OMI. Sterling Capital Management LLC increased its holdings in Owens & Minor by 758.3% during the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company’s stock valued at $27,000 after buying an additional 1,820 shares during the last quarter. Blue Trust Inc. raised its position in Owens & Minor by 57.4% in the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock worth $57,000 after acquiring an additional 1,600 shares during the period. KBC Group NV boosted its stake in shares of Owens & Minor by 98.2% during the 4th quarter. KBC Group NV now owns 4,434 shares of the company’s stock worth $58,000 after acquiring an additional 2,197 shares during the last quarter. Meeder Asset Management Inc. grew its position in shares of Owens & Minor by 844.1% during the 3rd quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock valued at $141,000 after acquiring an additional 8,061 shares during the period. Finally, Cetera Investment Advisers purchased a new stake in shares of Owens & Minor in the 4th quarter worth $140,000. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Price Performance

Shares of OMI stock opened at $9.66 on Thursday. The business’s fifty day moving average is $11.14 and its 200 day moving average is $12.97. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The stock has a market cap of $746.52 million, a price-to-earnings ratio of -14.87, a PEG ratio of 0.20 and a beta of 0.61. Owens & Minor has a twelve month low of $6.07 and a twelve month high of $28.35.

Owens & Minor (NYSE:OMI) last released its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.68 billion. During the same period in the prior year, the firm earned $0.69 EPS. The company’s revenue was up 1.5% compared to the same quarter last year. Research analysts expect that Owens & Minor will post 1.51 EPS for the current fiscal year.

Owens & Minor announced that its board has approved a share repurchase program on Friday, February 28th that authorizes the company to repurchase $100.00 million in shares. This repurchase authorization authorizes the company to buy up to 13.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its stock is undervalued.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.